Neurotransmitters and Action Potentials
Neurotransmitter Release and Action Potential Generation
Neurotransmitter Release
Neurotransmitters are released into the synaptic cleft and bind to receptor proteins on the postsynaptic plasma membrane.
If the neurotransmitter results in an excitatory postsynaptic potential (EPSP), it leads to an excitatory graded potential.
Graded Potentials:
Defined as depolarizations of variable strengths, i.e., they can vary in intensity.
Example ranges include:
Very weak: from -90 mV to -87 mV
Stronger: from -90 mV to -70 mV
Important to note that these potentials must sum collectively to reach a threshold level to trigger an action potential at the axonal hillock.
Graded Potentials and Ion Movement
These potentials are either short-lived due to efflux (outflow) and influx (inflow) of ions.
Key point: the graded potential must accumulate to reach the threshold for an action potential to occur.
Presynaptic Mechanisms
The presynaptic membrane contains a specialized pump known as a reuptake pump or reuptake protein, responsible for transporting neurotransmitters from the synaptic cleft back into the presynaptic neuron, aiding in homeostasis and conservation of resources.
This process prevents wastage of neurotransmitters and contributes to maintaining effective synaptic transmission.
Fate of Neurotransmitters
Neurotransmitters can:
Diffuse away from the synapse due to concentration gradients (moving from high to low concentrations).
Bind to receptor sites, continuing influence on postsynaptic neurons.
Be broken down by enzymes specific to that neurotransmitter (e.g., acetylcholine broken down by acetylcholinesterase (ACE)).
Taken in by astrocytes that also regulate ion concentrations in the extracellular space.
Calcium and Exocytosis
The action potential in the presynaptic neuron leads to the opening of voltage-gated calcium channels, allowing calcium ions to flow into the axon terminal.
This influx causes exocytosis, the process where neurotransmitter-filled vesicles fuse with the presynaptic membrane to release their contents.
SNARE Proteins in Synaptic Function
SNARE Proteins include v-SNAREs (e.g., synaptobrevin) and t-SNAREs (e.g., syntaxin and SNAP-25), which interact to facilitate the merging of vesicles with the cell membrane.
Once calcium binds to the receptor protein synaptotagmin, it initiates a conformational change that triggers the SNARE protein interaction, leading to vesicle fusion.
Action of Calcium
Calcium binds to synaptotagmin, subsequently influencing the coil and merge action of the v-SNARE and t-SNARE proteins.
This zipper-like action effectively pulls the membranes of the vesicle and presynaptic terminal together, eventually leading to neurotransmitter release into the synapse.
Neurotransmitter Reuptake and Implications
After release, neurotransmitters act until they are taken back, broken down, or diffused away. For instance,
Selective Serotonin Reuptake Inhibitors (SSRIs): Work by blocking serotonin reuptake, enhancing mood.
Medications like Adderall primarily enhance dopamine action but can lead to side effects like increased heart rate and anxiety.
Latched Potentials Overview
Phase 1: Resting State of the Postsynaptic Cell
The voltage-gated potassium channel's activation gate is closed but the inactivation gate remains open.
Repolarization occurs after depolarization, leading to a return toward the resting state
There is a slight undershoot or hyperpolarization due to extended opening of the potassium channels, leading to the refractory period after an action potential.
Absolute Refractory Period: No stimulus can result in another depolarization.
Relative Refractory Period: A stronger stimulus can trigger depolarization during this time window. Explanations suggest that hyperpolarization requires significantly stronger stimuli.
Graded Muscle Responses and Signal Transmission
Continuous Conduction vs. Saltatory Conduction:
Saltatory conduction, due to myelination, allows action potentials to jump between nodes of Ranvier, leading to faster signal transmission compared to unmyelinated fibers.
Implication of conduction velocity influenced by axon diameter and myelination.
Group A fibers are large and myelinated, allowing for rapid conduction; Group C fibers are small and unmyelinated, leading to slower transmission.
Influences of Ion Concentration and Electrolyte Problems
Hyperkalemia: Elevated extracellular potassium levels that reduce the concentration gradient, causing depolarization and increased excitability of cells.
Hypokalemia: Low potassium leading to hyperpolarization, resulting in muscle weakness and fatigue.
Hyponatremia and Hypernatremia: Affect sodium levels, influencing cell excitability but primarily affect resting membrane potential through potassium dynamics.
Neurotransmitter Functions
Acetylcholine (ACh): Used in both central and peripheral nervous systems, it can have excitatory or inhibitory effects depending on the receptor type.
ACh binding leads to direct channel opening in skeletal muscle and influences cardiac muscle mechanisms preventing excessive heart rate increases.
Nicotinic receptors in skeletal muscles are directly responsible for contraction, whereas different receptors determine outcomes in cardiac muscle.
Conclusion on Neurotransmitter Role
Neurotransmitters act as localized chemical messengers crucial for neuron communication at synapses, determining the functional outcomes based on specific receptor interactions.
Summary Concepts
Sodium-Potassium Pump: Maintains ion gradient essential for action potentials by actively transporting 3 Na out per 2 K in.
Action Potentials: Represent a rapid reversal of membrane potentials, characterized by phases of depolarization and repolarization.
Myelination: Increases the efficiency of neuron signaling and speeds up action potentials, critical for the autonomic nervous system functions.
Refractory Periods: Essential for ensuring unidirectional propagation of action potentials and allowing recovery time for neurons.
Effects of Neurotransmitter Dynamics: Highlight the complexities of neuropharmacology and implications for drug therapy in treating neurological and psychological disorders.